A triple combination of treatments on moderate COVID-19
Bao ChunMiao,
Li BinBin,
Zhou YuFeng
Affiliations
Bao ChunMiao
Department of Respiratory Medicine, The Affiliated Yangming Hospital of Ningbo University, Yuyao People’s Hospital of Zhejiang Province, Zhejiang, China
Li BinBin
Department of Infection, YongJia County People’s Hospital, Shangtang Road, Wenzhou, 325000, China
Zhou YuFeng
Department of Intensive Care Unit, The Affiliated Yangming Hospital of Ningbo University, Yuyao People’s Hospital of Zhejiang Province, Zhejiang, China
A triple combination of interferon (IFN) α-2b, lopinavir tablets, and umifenovir was used to treat COVID-19 patients. It is important to explore whether the benefit of this therapy is time dependent.
